Patents by Inventor Neil Desai

Neil Desai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210032290
    Abstract: The present invention pertains to peptides and peptide-containing complexes/nanoparticles that are useful for stabilizing and delivering cargo molecules such as nucleic acids.
    Type: Application
    Filed: July 15, 2020
    Publication date: February 4, 2021
    Inventors: Gilles DIVITA, Neil DESAI
  • Publication number: 20200332300
    Abstract: The present invention relates to compositions comprising one or more active agents that selectively modulate the expression of two or more genes, for example at the post-transcription level, that are involved in fibrosis and/or inflammatory conditions. Also provided are methods of using, such compositions for treating fibrotic diseases, as well as other diseases including inflammatory diseases and cancer.
    Type: Application
    Filed: January 30, 2020
    Publication date: October 22, 2020
    Inventor: Neil DESAI
  • Publication number: 20200323964
    Abstract: The present invention pertains to peptide-containing complexes/nanoparticles that are useful for delivering into a cell one or more mRNA (such as therapeutic mRNA, e.g., mRNA encoding a tumor suppressor protein).
    Type: Application
    Filed: October 15, 2018
    Publication date: October 15, 2020
    Inventors: Neil DESAI, Gilles DIVITA
  • Patent number: 10745440
    Abstract: The present invention pertains to peptides and peptide-containing complexes/nanoparticles that are useful for stabilizing and delivering cargo molecules such as nucleic acids.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: August 18, 2020
    Assignee: Aadigen, LLC
    Inventors: Gilles Divita, Neil Desai
  • Publication number: 20200241935
    Abstract: One embodiment provides for a wearable electronic device comprising a display device, a memory device, and one or more processors to execute instructions stored in the memory device. The instructions cause the one or more processors to receive an interaction to transition an application to a front-most state on the wearable electronic device, receive a request to initiate an activity via the application in the front-most state, detect that the wearable electronic device has transitioned to a low power mode, and enable enhanced functionality for the application in the front-most state during the low power mode while the application is in the front-most stat. Enabling enhanced functionality for the application in the front-most state includes, for example, increasing an execution priority of the application while the application is in the front most state.
    Type: Application
    Filed: February 27, 2020
    Publication date: July 30, 2020
    Inventors: Mike Lamb, Neil Desai, Antony J. Dzeryn, Greg Novick, Kevin McAtee, Ziv Wolkowicki
  • Publication number: 20200172913
    Abstract: The present invention pertains to peptide-containing complexes/nanoparticles that are useful for delivering into a cell one or more viruses (such as recombinant viruses, e.g., recombinant AAV) and/or masking antigenic epitopes on the one or more viruses.
    Type: Application
    Filed: August 9, 2018
    Publication date: June 4, 2020
    Inventors: Neil DESAI, Gilles DIVITA
  • Patent number: 10592305
    Abstract: A wearable electronic device includes an application processor to execute applications on the device. A user interface for the application can be displayed on a display of the wearable device. Some applications executed on the wearable device are associated with an activity session, such as, for example, a turn-by-turn navigation session, an exercise session, a media playback session. For the duration of this session, such applications can be flagged for persistent display on the wearable device and will be displayed upon activation of the wearable device in place of the default application.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: March 17, 2020
    Assignee: Apple Inc.
    Inventors: Mike Lamb, Neil Desai, Antony J. Dzeryn, Greg Novick, Kevin McAtee, Ziv Wolkowicki
  • Patent number: 10397349
    Abstract: Efficiently identifying transactions processed by a software application, such as a server application is disclosed. In one embodiment, transactions are identified by applying a set of rules to communications between a client and server to determine whether certain patterns are in the communications. For example, the rules may look for some combination of parameters in the transactions. As a particular example, the rules may be used to look for parameters in HTTP requests. The rules are organized in a way that allows efficient processing. For example, the rules may be organized based on the frequency with which the parameters are expected to occur in the transactions and the frequency with which each transaction is expected to occur. The rules may be updated if the expected frequencies deviate from actual frequencies, such that the rules can be organized for more efficient processing.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: August 27, 2019
    Assignee: CA, Inc.
    Inventors: Marco Gagliardi, Neil Desai
  • Publication number: 20190211317
    Abstract: The present invention pertains to peptide-containing complexes/nanoparticles that are useful for stabilizing and/or delivering one or more molecules of a genome-editing system, such as proteins and/or nucleic acids, for example CRISPR proteins and/or nucleic acids.
    Type: Application
    Filed: May 26, 2017
    Publication date: July 11, 2019
    Applicant: Aadigen, LLC
    Inventors: Gilles DIVITA, Neil DESAI
  • Publication number: 20190002499
    Abstract: The present invention pertains to peptides and peptide-containing complexes/nanoparticles that are useful for stabilizing and delivering cargo molecules such as nucleic acids.
    Type: Application
    Filed: December 23, 2015
    Publication date: January 3, 2019
    Inventors: Gilles DIVITA, Neil DESAI
  • Publication number: 20180336074
    Abstract: One embodiment provides for a method of determining application display persistence on a wearable electronic device, the method comprising receiving an application programming interface (API) call from an application to perform an action on the wearable electronic device; beginning a session on the wearable electronic device in response to determining that the API call is associated with the beginning of a session; determining, based on the application, a persistence level to apply to the application; flagging the application associated with the session as persistent; and displaying a persistent application at a next activation of the wearable electronic device in place of a default application associated with the wearable electronic device.
    Type: Application
    Filed: December 6, 2017
    Publication date: November 22, 2018
    Inventors: Mike Lamb, Neil Desai, Antony J. Dzeryn, Greg Novick, Kevin McAtee, Ziv Wolkowicki
  • Publication number: 20180187199
    Abstract: The present invention relates to compositions comprising one or more active agents that selectively modulate the expression of two or more genes, for example at the post-transcription level, that are involved in fibrosis and/or inflammatory conditions. Also provided are methods of using such compositions for treating fibrotic diseases, as well as other diseases including inflammatory diseases and cancer.
    Type: Application
    Filed: September 11, 2017
    Publication date: July 5, 2018
    Inventor: Neil DESAI
  • Publication number: 20170126823
    Abstract: Efficiently identifying transactions processed by a software application, such as a server application is disclosed. In one embodiment, transactions are identified by applying a set of rules to communications between a client and server to determine whether certain patterns are in the communications. For example, the rules may look for some combination of parameters in the transactions. As a particular example, the rules may be used to look for parameters in HTTP requests. The rules are organized in a way that allows efficient processing. For example, the rules may be organized based on the frequency with which the parameters are expected to occur in the transactions and the frequency with which each transaction is expected to occur. The rules may be updated if the expected frequencies deviate from actual frequencies, such that the rules can be organized for more efficient processing.
    Type: Application
    Filed: January 12, 2017
    Publication date: May 4, 2017
    Applicant: CA, Inc.
    Inventors: Marco Gagliardi, Neil Desai
  • Patent number: 9569326
    Abstract: Efficiently identifying transactions processed by a software application, such as a server application is disclosed. In one embodiment, transactions are identified by applying a set of rules to communications between a client and server to determine whether certain patterns are in the communications. For example, the rules may look for some combination of parameters in the transactions. As a particular example, the rules may be used to look for parameters in HTTP requests. The rules are organized in a way that allows efficient processing. For example, the rules may be organized based on the frequency with which the parameters are expected to occur in the transactions and the frequency with which each transaction is expected to occur. The rules may be updated if the expected frequencies deviate from actual frequencies, such that the rules can be organized for more efficient processing.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: February 14, 2017
    Assignee: CA, Inc.
    Inventors: Marco Gagliardi, Neil Desai
  • Publication number: 20160243074
    Abstract: The invention provides methods for predicting or determining the response of a mammalian tumor to a chemotherapeutic agent and for treating a mammalian tumor comprising detecting and quantifying the SPARC protein or RNA in a sample isolated from the mammal. The invention further provides kit for predicting the response of a mammalian tumor to a chemotherapeutic agent, comprising a means for the isolation of protein or RNA from the tumor, a SPARC protein or RNA detection and quantification means, control RNAs, and rules for predicting the response of the tumor based on the level of SPARC protein or RNA in tumor.
    Type: Application
    Filed: May 6, 2016
    Publication date: August 25, 2016
    Inventors: Vuong Trieu, Neil Desai, Patrick Soon-Shiong
  • Patent number: 9409903
    Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: August 9, 2016
    Assignee: NantBioScience, Inc.
    Inventors: Chunlin Tao, Qinwei Wang, David Ho, Laxman Nallan, Tulay Polat, Xiaowen Sun, Neil Desai
  • Patent number: 9345699
    Abstract: The invention provides isoquinoline, quinoline, and quinazoline derivatives to treat a variety of disorders, diseases and pathologic conditions, and more specifically to the use of isoquinoline, quinoline, and quinazoline derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds to the treatment of hyperproliferative diseases and pathologic angiogenesis.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: May 24, 2016
    Assignee: NantBioScience, Inc.
    Inventors: Chunlin Tao, Xiaowen Sun, Hongna Han, Lukasz Koroniak, Neil Desai
  • Patent number: D843256
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: March 19, 2019
    Assignee: Tiffany and Company
    Inventors: Francesca Amfitheatrof, Alex Hossick, Cary James, Michal Dayan, Paul Harrison, Rachel Fine, Young Byun, Neil Desai
  • Patent number: D848892
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: May 21, 2019
    Assignee: Tiffany and Company
    Inventors: Francesca Amfitheatrof, Alex Hossick, Cary James, Michal Dayan, Paul Harrison, Rachel Fine, Young Byun, Neil Desai
  • Patent number: D906154
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: December 29, 2020
    Assignee: TIFFANY AND COMPANY
    Inventors: Eva Zuckerman, Young Byun, Seohee Koh, Stephane Krumenacker, Cary James, Neil Desai